Craig-Hallum analyst Chad Bennett downgrades Quotient Technology (NYSE:QUOT) from Buy to Hold.
Analyst Ratings For Root
6 analysts have expressed a variety of opinions on Root (NASDAQ:ROOT) over the past quarter, offering a diverse…
Craig-Hallum Downgrades Quotient Technology to Hold
Craig-Hallum analyst Chad Bennett downgrades Quotient Technology (NYSE:QUOT) from Buy to Hold.
Related Posts
FDA Grants Lantern Pharma Orphan Drug Designation For Drug Candidate LP-284 In High-Grade B-cell Lymphomas
The Orphan Drug Designation strengthens LP-284's clinical development path and can provide for additional market exclusivity and commercial protection.Lantern has initiated a first-in-human Phase 1 trial (NCT06132503)
Analyst Expectations for Quanta Services’s Future
Over the past 3 months, 8 analysts have published their opinion on Quanta Services (NYSE:PWR) stock. These analysts…
Here’s How Much $1000 Invested In O’Reilly Automotive 15 Years Ago Would Be Worth Today
O’Reilly Automotive (NASDAQ:ORLY) has outperformed the market over the past 15 years by 15.09% on an annualized basis…